The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Aghazadeh Behzad | Director, 10% Owner | Buy(P) | 8K | $18.25 | $144K |
| Jul 27, 2026 | AH Bio Fund II, L.P. | 10% Owner | Conversion(C) | 4.1M | — | $0 |
| Jul 27, 2026 | AH Bio Fund II, L.P. | 10% Owner | Conversion(C) | 12.2M | — | $0 |
| Jul 27, 2026 | AH Bio Fund II, L.P. | 10% Owner | Buy(P) | 333K | $15.00 | $5.0M |
| Jul 27, 2026 | AH Bio Fund II, L.P. | 10% Owner | Conversion(C) | 698K | — | — |
| Jul 27, 2026 | AH Bio Fund II, L.P. | 10% Owner | Conversion(C) | 2.1M | — | — |
| Jul 27, 2026 | Gordon Carl L | Director | Conversion(C) | 2.1M | — | $0 |
| Jul 27, 2026 | Gordon Carl L | Director | Buy(P) | 1.0M | $15.00 | $15.0M |
| Jul 27, 2026 | Gordon Carl L | Director | Conversion(C) | 349K | — | — |
| Jul 27, 2026 | Orbimed Advisors LLC | Director | Conversion(C) | 2.1M | — | $0 |
| Jul 27, 2026 | Orbimed Advisors LLC | Director | Buy(P) | 1.0M | $15.00 | $15.0M |
| Jul 27, 2026 | Orbimed Advisors LLC | Director | Conversion(C) | 349K | — | — |
| Jul 27, 2026 | Doudna Jennifer A | 10% Owner | Conversion(C) | 74K | — | — |
| Jul 27, 2026 | Doudna Jennifer A | 10% Owner | Conversion(C) | 13K | — | — |
| Jul 24, 2026 | Aghazadeh Behzad | Director, 10% Owner | Buy(P) | 50K | $22.31 | $1.1M |
| Jul 24, 2026 | Aghazadeh Behzad | Director, 10% Owner | Buy(P) | 2.3M | $15.00 | $35.0M |
| Jul 23, 2026 | Staahl Brett | 10% Owner | Grant(A) | 19K | — | $0 |
| Jul 23, 2026 | Staahl Brett | 10% Owner | Grant(A) | 19K | — | $0 |
| Jul 23, 2026 | Lucas Svetlana | Chief Business Officer | Grant(A) | 109K | — | $0 |
| Jul 23, 2026 | Lucas Svetlana | Chief Business Officer | Grant(A) | 109K | — | $0 |
| Jul 23, 2026 | Lucas Svetlana | Chief Business Officer | Buy(P) | 3K | $15.00 | $45K |
| Jul 23, 2026 | Parrot David | Chief Financial Officer | Grant(A) | 109K | — | $0 |
| Jul 23, 2026 | Parrot David | Chief Financial Officer | Grant(A) | 109K | — | $0 |
| Jul 23, 2026 | Parrot David | Chief Financial Officer | Buy(P) | 1K | $15.00 | $20K |
| Jul 23, 2026 | Parrot David | Chief Financial Officer | Buy(P) | 1K | $15.00 | $20K |
| Jul 23, 2026 | Bleharski Joshua | Director | Grant(A) | 15K | — | $0 |
| Jul 23, 2026 | Watson James Dean | Director | Grant(A) | 15K | — | $0 |
| Jul 23, 2026 | Gordon Carl L | Director | Grant(A) | 15K | — | $0 |
| Jul 23, 2026 | Oakes Benjamin L. | President, CEO, Director | Grant(A) | 430K | — | $0 |
| Jul 23, 2026 | Oakes Benjamin L. | President, CEO, Director | Grant(A) | 265K | — | $0 |
| Jul 23, 2026 | Aghazadeh Behzad | Director | Grant(A) | 15K | — | $0 |
| Mar 13, 2026 | Staahl Brett | 10% Owner | Grant(A) | 5K | — | $0 |
| Mar 13, 2026 | Lucas Svetlana | Chief Business Officer | Grant(A) | 10K | — | $0 |
| Mar 13, 2026 | Parrot David | Chief Financial Officer | Grant(A) | 9K | — | $0 |
| Mar 13, 2026 | Oakes Benjamin L. | President, CEO, Director | Grant(A) | 13K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2020-03-30 → 2026-07-30. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).